Taking Benefit of Economies of Scale in Producing Vaccine in Natural Setup of Human Body: Coronavirus Pandemic
5 Pages Posted: 30 Mar 2020 Last revised: 31 Mar 2020
Date Written: March 29, 2020
This article is an attempt to provide lead for mass production of coronavirus vaccine (if the vaccines are produced by any research laboratories, clinically successful and approved by regulatory body like FDA). The unprecedented and unique spread of coronavirus has devastated the whole world and its economy. Scientists, research laboratories and governments are working hard to develop vaccine to combat the deadly disease. Once a reliable vaccine is produced, the next challenge will be to produce in large quantity and supply feasible dose units of vaccine across the globe. Based on primary understanding, we want to provide a lead, if human body can be used to produce further dose of vaccine, if artificially vaccine is injected to a person, his body may have capacity to produce transferable antigens to another human. This experiment also required theoretical study and assessment or evaluation of the result; i.e. practical aspects of possibility of production of antibody, its transferability, feasibility, safety, potency of antigens and immunity developed in the recipient.
Keywords: Coronavirus, vaccine, economies of scale, human body, antigen, natural production
JEL Classification: I00
Suggested Citation: Suggested Citation